Search results summary

Search criteria

List of returned drug products
Products returned by the search are listed, including their status, DIN number, name, class, total count of active ingredients and the name of one, etc. Clicking on the value in the DIN column returns more complete information about the related product.
Status	DIN	Company	Product	Class	PM ^{See footnote1}	Schedule	# ^{See footnote2}	A.I. name ^{See footnote3}	Strength
Marketed	02518627	INCYTE CORPORATION	MINJUVI	Human	Yes	Prescription	1	TAFASITAMAB	200 MG / VIAL
Marketed	02518627	INCYTE CORPORATION	MINJUVI	Human	Yes	Schedule D	1	TAFASITAMAB	200 MG / VIAL
Marketed	02552434	INCYTE CORPORATION	OPZELURA	Human	Yes	Prescription	1	RUXOLITINIB (RUXOLITINIB PHOSPHATE)	1.5 % / W/W
Marketed	02519933	INCYTE CORPORATION	PEMAZYRE	Human	Yes	Prescription	1	PEMIGATINIB	4.5 MG
Marketed	02519941	INCYTE CORPORATION	PEMAZYRE	Human	Yes	Prescription	1	PEMIGATINIB	9 MG
Marketed	02519968	INCYTE CORPORATION	PEMAZYRE	Human	Yes	Prescription	1	PEMIGATINIB	13.5 MG
Approved	02555239	INCYTE CORPORATION	ZYNYZ	Human	Yes	Prescription Recommended	1	RETIFANLIMAB	25 MG / ML
Approved	02555239	INCYTE CORPORATION	ZYNYZ	Human	Yes	Schedule D	1	RETIFANLIMAB	25 MG / ML

Version 4.0.3